Kinetics Control Preferential Heterodimer Formation of Platelet-derived Growth Factor from Unfolded A- and B-chains*

Carsten MüllerDagger, Susanne Richter§, and Ursula Rinas

From the GBF National Research Center for Biotechnology, Biochemical Engineering Division, Mascheroder Weg 1, 38124 Braunschweig, Germany

Received for publication, December 4, 2002, and in revised form, February 26, 2003

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The folding and assembly of platelet-derived growth factor (PDGF), a potent mitogen involved in wound-healing processes and member of the cystine knot growth factor family, was studied. The kinetics of the formation of disulfide-bonded dimers were investigated under redox reshuffling conditions starting either from unfolded and reduced PDGF-A- or B-chains or an equimolar mixture of both chains. It is shown that in all cases the formation of disulfide-bonded dimers is a very slow process occurring in the time scale of hours with a first-order rate-determining step. The formation of disulfide-bonded PDGF-AA or PDGF-BB homodimers displayed identical kinetics, indicating that both monomeric forms as well as the dimerized homodimer have similar folding and assembly pathways. In contrast, the formation of the heterodimer occurred three times more rapidly compared with the formation of the homodimers. As both monomeric forms revealed similar renaturation kinetics, it can be concluded that the first-order rate-determining folding step does not occur during monomer folding but must be attributed to conformational rearrangements of the dimerized, not yet disulfide-bonded protein. These structural rearrangements allow a more rapid formation of intermolecular disulfide bonds between the two different monomers of a heterodimer compared with the formation of the disulfide bonds between two identical monomers. The preferential formation of disulfide-bonded heterodimers from an equimolar mixture of unfolded A- and B-chains is thus a kinetically controlled process. Moreover, similar activation enthalpies for the formation of all different isoforms suggest that faster heterodimerization is controlled by entropic factors.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Platelet-derived growth factor (PDGF)1 is a potent mitogen for cells of mesenchymal origin, i.e. smooth muscle cells, connective tissue cells, or blood cells (1-3). It is released by platelets upon wounding and plays an important role in stimulating adjacent cells to grow and thereby heal the wound (4). PDGF is a non-glycosylated protein that belongs to the family of dimeric cystine knot growth factors (5). The PDGF family consists of different gene products. The most prominent and long known members of this family are PDGF-A and -B. More recently, two new less abundant members, PDGF-C and -D, have been discovered (6, 7).

The two different homologous monomers of PDGF, denoted as A- and B-chains, are known to exist in the three natural occurring dimeric isoforms PDGF-AA, -AB, and -BB (8, 9). These different isoforms have apparently distinct biological functions indicated, e.g. by their different binding affinities to the two different types of PDGF receptors (10). However, the majority of PDGF purified from human platelets is the disulfide-bonded heterodimeric growth factor (11), suggesting that heterodimerization is favored when both genes are coexpressed. Also, PDGF-AB disulfide-bonded heterodimers are almost exclusively formed from an equimolar mixture of unfolded and reduced A- and B-chains when renaturation is carried out under conditions that allow disulfide bond reshuffling (12-14).

From all potential isoforms of the PDGF dimer, only the structure of the BB homodimer has been determined so far (Fig. 1; Ref. 15). PDGF-BB is an all-beta sheet protein of about 30 kDa and composed of two very flat subunits arranged head-to-tail and linked together by two intermolecular disulfide bonds (5, 15). In addition to intermolecular disulfide bonds, each monomer contains an unusual knot-like arrangement of three intramolecular disulfide bridges where one disulfide bond threads through a loop formed by the two other disulfide bonds (5, 15). As all members of the cystine knot growth factor family share strong structural homology, it is most likely that the other PDGF isoforms are of almost identical structure as the BB isoform.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 1.   Schematic presentation of the three-dimensional structure of PDGF-BB. A, the two monomers (depicted in green and blue) are connected head-to-tail via two intermolecular disulfide bonds. Each monomer contains a knot-like arrangement of three intramolecular disulfide bonds, where two disulfide bonds connect two beta -strands and form a ring structure, and the third disulfide bond threads through this ring and connects two additional beta -strands. The positions of the cysteines are indicated in yellow. The disulfide bonds are shown in red. The single tryptophan is indicated in violet. The gray rectangle underlays the area occupied by one subunit and the gray circle the position of the cystine knot in the other subunit. B, bowllike structure of a single subunit with the positions of the prolines indicated in gray. C, close-up of the local backbone conformation in the vicinity of the conserved cysteine (Cys43) involved in intermolecular disulfide-bonding. All solved structures of members of the cystine knot growth factor family show evidence for the presence of a conserved cis-proline (Ref. 15: PDGF-BB, Trp39-Pro40-cis-Pro41-Cys43; Refs. 30 and 31). The same motif is also present in the PDGF-A chain (PDGF-A, Trp35-Pro36-Pro37-Cys38), although the structures of PDGF-AA or PDGF-AB have not yet been determined.

The folding pathways of oligomeric proteins frequently exhibit very complex profiles, since unimolecular folding reactions and bimolecular association steps are involved (16, 17). In case of PDGF, the folding and association process becomes even more complex through the additional requirement for the formation of the unusual knot-like arrangement of the three intramolecular disulfide bridges and the formation of the two intermolecular disulfide bonds. Although many members of the cystine knot growth factor family are of enormous medical importance (e.g. PDGFs, transforming growth factors, bone morphogenetic proteins), almost no knowledge exists about the mechanisms governing their folding and assembly. Some more detailed studies have been carried out on the folding and association kinetics of brain-derived neurotrophic factor (18) and nerve growth factor (19). Both factors belong to a subgroup of the cystine knot growth factor family where the subunits are not connected by intermolecular disulfide bonds in the dimeric protein. Kinetic studies on the folding and assembly of those growth factors of the cystine knot family where the subunits are connected by disulfide bonds in the native protein are missing so far.

It was commonly accepted that the presence of the cystine knot is a prerequisite for the dimerization of proteins belonging to the cystine knot growth factor family (5). However, recent studies on the structure and stability of vascular endothelial growth factor, a member of PDGF superfamily of cystine knot growth factors, revealed that cystine deletion mutants lacking one of the two disulfide bonds forming the outer ring of the knot motif are still able to form disulfide-bonded dimers (20). Surprisingly, these mutants even revealed an increased thermodynamic stability although their thermal stability was severely reduced (20). However, the formation of the cystine knot appears to be indispensable for the biological activity of PDGF (21), while the intermolecular disulfide bridges have a stabilizing but non-essential effect on the biological activity (21, 22). PDGF is very prone to aggregation when renaturation is initiated by diluting unfolded and reduced monomers into a buffer, which allows refolding and disulfide bond reshuffling (14). Once folded, however, PDGF is a very stable protein withstanding temperatures of up to 100 °C (23).

Previously, we have presented a renaturation method based on the utilization of size exclusion chromatography, which circumvents aggregation during refolding and allows renaturation of PDGF at high protein concentrations (14). In this study, we present a kinetic analysis of the formation of disulfide-bonded dimers and propose a model for the folding pathway of the different isoforms of PDGF. The unfolded and reduced monomers of PDGF were subjected to size exclusion chromatography under renaturing conditions and the formation of disulfide-bonded dimers starting either from pure A- or B-chains or an equimolar mixture of both monomeric isoforms was followed in the eluate fraction.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

PDGF-BB Structure Visualization-- PDGF-BB structure data were obtained from the Protein Data Bank (www.rcsb.org/pdb/; accession number 1pdg) and visualized using the program RasMol, Version 2.7.2.1 (RasMol Molecular Renderer; R. Sayle, Glaxo Research and Development Greenford, Middlesex, UK).

Production and Purification of PDGF Isoforms-- The different PDGF isoforms were produced as inclusion bodies using the Escherichia coli strain TG1 carrying temperature-inducible expression vectors encoding either the PDGF A- or B-chain or a bicistronic vector encoding both chains synthesized in a 1:1 ratio upon induction (13). Production of PDGF was carried out in a high cell density cultivation procedure that has been described previously (24). Purification of unfolded and reduced PDGF monomers from solubilized PDGF containing inclusion bodies was done by size exclusion chromatography (SEC) under denaturing conditions (14).

Kinetic Analysis of PDGF Dimerization-- Purified, unfolded, and reduced PDGF monomers (either pure A-, or B-chains, or an equimolar mixture of the two chains) were subjected to SEC under conditions that allow refolding and reshuffling of disulfide bridges as described previously (14). Standard renaturation conditions by SEC were: 1 mol l-1 Tris-HCl (pH 7.8), 0.5 mol l-1 guanidinium hydrochloride (GdnHCl), 10 mmol l-1 glutathione reduced (GSH), 0.25 mmol l-1 glutathione oxidized (GSSG). Under these conditions, the eluted PDGF monomers were able to dimerize in the eluate fraction to yield the dimeric, disulfide-bonded, and biologically active growth factor (14). Aggregation of PDGF during the renaturation procedure was not observed unless otherwise indicated. The formation of disulfide-bonded dimers was followed in aliquots taken from the reaction mixture in the eluate fraction through disulfide trapping by irreversible blocking of free thiol groups and subsequent separation of monomeric and dimeric PDGF by gel electrophoresis under non-reducing conditions. Blocking of the free thiol groups by the addition of iodoacetate and gel electrophoresis was carried out as described previously (14). Gels were stained with Coomassie Brilliant Blue, and quantification of the monomeric and dimeric fraction of PDGF was carried out by densitometry (Hirschman elscript 400).

The putative reaction order for the rate-limiting step during dimerization of PDGF was determined from the slopes of the linearized kinetic equations assuming either a first-order (Equation 1),
<UP>ln</UP>[A]<SUB>t</SUB><UP> = ln</UP>[A]<SUB><UP>0</UP></SUB><UP> − ‖&Sgr;</UP>v<SUB>a</SUB><UP>‖ </UP>k<SUB><UP>1</UP></SUB>t (Eq. 1)
or a second-order rate-determining reaction (Equation 2),
<FR><NU><UP>1</UP></NU><DE>[A]<SUB>t</SUB></DE></FR><UP> = </UP><FR><NU><UP>1</UP></NU><DE>[A]<SUB><UP>0</UP></SUB></DE></FR><UP> + ‖&Sgr;</UP>v<SUB>a</SUB><UP>‖</UP>k<SUB><UP>2</UP></SUB>t (Eq. 2)
where [A]t and [A]0 are the monomer concentrations at times t and zero, respectively, Sigma va is the sum of the stoichiometric factors, and k1 and k2 are the rate constants for a first- or second-order reaction, respectively. By rearranging the kinetic Equations 1 and 2, the monomer turnover U can be simulated assuming either a first-order (Equation 3) or a second-order rate-determining reaction (Equation 4).
<UP>1 − </UP><FR><NU>[A]<SUB>t</SUB></NU><DE>[A]<SUB><UP>0</UP></SUB></DE></FR><UP> = </UP>U<UP> = 1 − </UP>e<SUP><UP>−‖&Sgr;</UP>v<SUB>a</SUB><UP>‖</UP>k<SUB><UP>1</UP></SUB>t</SUP> (Eq. 3)

<UP>1 − </UP><FR><NU>[A]<SUB>t</SUB></NU><DE>[A]<SUB><UP>0</UP></SUB></DE></FR><UP> = </UP>U<UP> = 1 − </UP><FR><NU><UP>1</UP></NU><DE><UP>1 + ‖&Sgr;</UP>v<SUB>a</SUB><UP>‖</UP>k<SUB><UP>2</UP></SUB>[A]<SUB><UP>0</UP></SUB>t</DE></FR> (Eq. 4)

In case of a unimolecular rate-limiting reaction, the monomer turnover with time should be independent of the initial monomer concentration (Equation 3), while a second-order rate-limiting reaction should be reflected by an increased monomer turnover with increasing initial monomer concentration (Equation 4). Best-fit simulations of the data from kinetic experiments for the determination of the rate constants and modeling of the monomer turnover were carried out using standard software.

The temperature dependence of the rate of dimerization was described by an Arrhenius relationship, i.e. a plot of lnk versus 1/T,
k=A<UP>exp</UP><FENCE><FR><NU><UP>&Dgr;</UP>S<SUP><UP>#</UP></SUP></NU><DE>R</DE></FR></FENCE><UP>exp</UP><FENCE>−<FENCE><FR><NU><UP>&Dgr;</UP>H<SUP><UP>#</UP></SUP></NU><DE>R</DE></FR> − <FR><NU><UP>1</UP></NU><DE>T</DE></FR></FENCE></FENCE> (Eq. 5)
where k is the experimentally determined rate constant, A is a constant in the activated complex theory, Delta S# and Delta H# the entropy and enthalpy of activation of the reaction, respectively, T the temperature, and R the universal gas constant. If there is linearity for the temperature dependence of the rate constant, the enthalpy and entropy of activation can be determined from the slope and the y intercept of Equation 5, respectively.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Kinetics of Formation of Disulfide-bonded PDGF-AB Dimers from Unfolded and Reduced PDGF-A and -B Monomers-- The kinetics of the formation of disulfide-bonded dimers of PDGF were investigated under redox reshuffling conditions starting from an equimolar mixture of completely unfolded and reduced A- and B-chains (Fig. 2A). The kinetic data are well described either by assuming a first- or a second-order rate-determining reaction and the putative rate constants extracted from the slopes of the linearized kinetic equations (cf. experimental procedures) were determined to be k1 = 1.5 10-5 s-1 or k2 = 2.5 mol-1 l s-1, respectively (Fig. 2B).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2.   Kinetics of formation of disulfide-bonded PDGF-AB dimers from unfolded and reduced PDGF-A and -B monomers. A, time course data of the relative concentrations of PDGF-A and -B monomers () and disulfide-bonded dimers (black-square) after subjecting an equimolar mixture of unfolded and reduced PDGF-A and -B chains to SEC under renaturing conditions. Time zero indicates the start of the kinetic experiment in the eluate fraction immediately after elution of monomeric PDGF-A and -B from the SEC column. B, determination of the rate constants assuming either a first-order () or a second-order rate-determining step (open circle ) as described under "Experimental Procedures." The experimental conditions were as follows: 0.1 mol l-1 Tris-HCl (pH 7.8), 0.5 mol l-1 GdnHCl, 10 mmol l-1 GSH, 0.25 mmol l-1 GSSG, 8.9 µmol l-1 (110 µg ml-1) PDGF-A and -B monomers; T = 25 °C.

To discriminate between a first- and a second-order rate-limiting reaction controlling the formation of disulfide-bonded PDGF dimers, renaturation experiments were carried out with varying initial monomer concentrations (Fig. 3). The kinetic analysis revealed an independence of the monomer turnover at given time points on the initial monomer concentration (Fig. 3A), thus clearly excluding a second-order rate-limiting step in the renaturation of PDGF-AB. In addition, kinetic modeling revealed that the formation of the disulfide-bonded dimer is best described by a first-order rate-determining reaction (Fig. 3B). Deviation of the predicted monomer turnover from the experimental data originates from the formation of soluble off-pathway products, which are not able to form native PDGF-AB. To account for the incomplete monomer turnover, the kinetic model was further refined by including an additional step leading to the irreversible formation of misfolded off-pathway products (Fig. 4A). The experimental data are now well described by the productive first-order reaction with the rate constant of k1 = 1.5 10-5 s-1 yielding the native disulfide-bonded PDGF-AB dimer and an unproductive reaction with a rate constant of k1' = 7.5 10-6 s-1 leading to non-native off-pathway products (Fig. 4B).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 3.   Analysis of the monomer turnover for the determination of the reaction order of the rate-limiting step during the formation of disulfide-bonded PDGF-AB. A, determination of the monomer turnover at different time points with varying initial monomer concentrations: 1 h (black-square), 5 h (), 10 h (), and 20 h (open circle ) after eluting monomeric PDGF-A and -B from the SEC column. B, time course data of the monomer turnover of PDGF-A and -B starting with initial monomer concentrations of 1.9 µmol l-1 (black-triangle), 4.6 µmol l-1 (), 6.2 µmol l-1 (down-triangle), 7.4 µmol l-1 (), 8.0 µmol l-1 (diamond ), 8.9 µmol l-1 (black-square), and 47 µmol l-1 (triangle ) are shown. In addition, best fit simulations are depicted assuming a first-order with k1 = 1.5 10-5 s-1 (thick line) or a second-order rate-limiting step with k2 = 2.5 mol-1 l s-1 for the renaturation of PDGF-AB: 1.9 µmol l-1 (23.5 µg ml-1), · · ·; 4.6 µmol l-1 (56.9 µg ml-1), -··-; 7.4 µmol l-1 (91.5 µg ml-1), thin line; 8.9 µmol l-1 (110 µg ml-1), - - -; and 47 µmol L-1 (581 µg ml-1), --- --- ---. Experimental conditions were the same as described in the legend to Fig. 2 except for the initial concentrations of PDGF-A and -B monomers.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 4.   Simplified model for the formation of disulfide-bonded PDGF-AB dimers from unfolded and reduced PDGF-A and -B monomers. A, simplified model for the formation of disulfide-bonded PDGF-AB dimers additionally including the formation of non-native off-pathway folding products Mmisfolded incompetent for the formation of native disulfide-bonded PDGF-AB dimers. B, modeling of the kinetics assuming a first-order rate-limiting step with k1 = 1.5 10-5 s-1 for the formation of the disulfide-bonded PDGF-AB dimer. Formation of Mmisfolded is described assuming a first-order rate-limiting step with k1' = 7.5 10-6 s-1. In addition, the experimental time course data of the relative concentrations of PDGF-A and -B monomers () and disulfide-bonded dimers (black-square) are shown. Experimental conditions were the same as described in the legend to Fig. 2.

A variation of the GdnHCl concentration between 0.25 and 1.5 mol l-1 in the renaturation buffer revealed a strong decrease in the rate of the formation of the disulfide-linked dimer with increasing concentrations of the chaotropic agent (Fig. 5). The graphic representation of the rate constants in a "chevron plot" revealed a linear dependence on the GdnHCl concentration by anticipating a first-order rate-limiting step for the generation of the disulfide-linked PDGF-AB dimer (Fig. 5B). Final yields of disulfide-linked PDGF-AB dimers increased from 13 to 75% by decreasing the concentration of GdnHCl from 1.5 to 0.25 mol l-1. At 2 mol l-1 GdnHCl, formation of disulfide-linked dimers was not detectable (data not shown).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5.   GdnHCl dependence of formation of disulfide-bonded PDGF-AB dimers from unfolded and reduced PDGF-A and -B monomers. A, time-dependent monomer turnover of PDGF-A and -B at GdnHCl concentrations ranging from 0.25 to 1.5 mol l-1: 0.25 mol l-1 GdnHCl (black-square), 0.5 mol l-1 GdnHCl (), 0.8 mol l-1 GdnHCl (), 1.2 mol l-1 GdnHCl (black-triangle), and 1.5 mol l-1 GdnHCl (triangle ). B, GdnHCl dependence of the kinetic rate constant k1 assuming a first-order rate-limiting reaction. Experimental conditions were the same as described in the legend to Fig. 2, except for the GdnHCl concentrations.

Kinetics of Formation of Disulfide-bonded Dimers of the Different PDGF Isoforms-- A unimolecular rate-limiting reaction during the formation of the disulfide bonded PDGF dimer could either indicate a rate-limiting folding reaction on the level of the monomeric chain or structural rearrangements on the level of the dimeric not yet disulfide-bonded growth factor. To discriminate between these two possibilities, a kinetic study of the formation of disulfide-bonded dimers was carried out using either the purified A- or B-chains or an equimolar mixture of both chains (Fig. 6). The formation of disulfide-bonded PDGF-AA or PDGF-BB homodimers displayed identical kinetics indicating that both monomeric forms as well as the dimerized homodimer have similar folding and assembly pathways. In contrast, disulfide-bonded heterodimers were formed three times more rapidly (k1 = 1.5 10-5 s-1, experimental conditions, cf. Fig. 6) compared with the formation of the two different disulfide-bonded homodimers from either pure A- or B-chains (k1 = 0.5 10-5 s-1, experimental conditions, cf. Fig. 6) when renaturation was started from an equimolar mixture of both chains.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 6.   Kinetics of formation of disulfide-bonded PDGF dimers of the different PDGF isoforms from unfolded and reduced PDGF monomers. The time-dependent monomer turnover of the three different PDGF isoforms PDGF-A, PDGF-A and -B, and PDGF-B are shown starting with initial monomer concentrations of: 0.8 µmol l-1 PDGF-A (), 9.25 µmol l-1 PDGF-A and -B (), and 3.5 µmol l-1 PDGF-B (open circle ). Experimental conditions were the same as described in the legend to Fig. 2, except that the temperature was 35 °C.

At all temperatures ranging from 4 °C to 45 °C heterodimerzation occurred more rapidly compared with the formation of homodimers (Fig. 7 and Table I), suggesting a general preference for the formation of the heterodimer. Also, the kinetics of homodimerization of the two different PDGF-AA or -BB isoforms did not show any significant difference in the temperature range studied, supporting the conclusion that homodimerization of either PDGF-AA or -BB follows most likely similar pathways.


                              
View this table:
[in this window]
[in a new window]
 
Table I
Temperature dependence of the renaturation of the different PDGF isoforms
Experimental conditions were the same as described in the legend to Fig. 7.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 7.   Arrhenius plots of the rate constants of the formation of disulfide-bonded PDGF dimers of the different PDGF isoforms from unfolded and reduced PDGF monomers. The rate constants of dimerization of the three different PDGF isoforms PDGF-AA, PDGF-AB, and PDGF-BB were determined at temperatures ranging from 4 to 45 °C assuming a first-order rate-determining reaction. The initial monomer concentrations were: 0.8 µmol l-1 PDGF-A (), 9.25 µmol l-1 PDGF-A and -B (), and 3.5 µmol l-1 PDGF-B (open circle ). Experimental conditions were the same as described in the legend to Fig. 2, except for the temperatures.

During the renaturation of all the three different PDGF isoforms aggregation was not observed up to temperatures of 35 °C. However at 45 °C, partial aggregation of all PDGF isoforms occurred. A summary of the results from the renaturation experiments carried out at the different temperatures is shown in Table I. An estimation of the activation enthalpies from the Arrhenius plots (Fig. 7; only data from 4 to 35 °C) of either homo- or heterodimerization did not reveal a significant difference for the different PDGF isoforms. Assuming a first-order rate-limiting renaturation step, activation enthalpies in the range of 70-80 kJ mol-1 were estimated for the formation of PDGF-AA, -AB, or -BB.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Subunit association can be a very fast process with rate constants in the order of 107 mol-1 l s-1 (e.g. Ref. 25) that are encountered in diffusion-controlled reactions. However, when folding and association is connected with the formation of intra- and intermolecular disulfide bonds, e.g. during renaturation of antibody fragments, the regain of the biological activity can occur in the time scale of hours to days (26).

The formation of disulfide-bonded dimers of PDGF is also a very slow process occurring in the time scale of hours. Studies on the folding and association of brain-derived neurotrophic factor (18) and nerve growth factor (19), growth factors where the subunits are not connected by intermolecular disulfide bonds, also revealed slow renaturation kinetics, although, in general, little information exists on the folding and association pathways of dimeric proteins of the cystine knot growth factor family.

The rate-limiting step during the renaturation of a dimeric protein can either be a first-order step resulting from unimolecular conformational changes or a second-order step originating from the encounter and assembly of the subunits. The experimental results clearly show that the formation of the PDGF dimer is a process controlled by a first-order reaction, thus proving that the encounter of the monomeric chains to form the dimeric growth factor is not the rate-limiting step in the renaturation of PDGF. A first-order rate-determining reaction during the renaturation of a multimeric protein is not unusual. For example, the kinetic analysis of the renaturation of the homodimeric mitochondrial malate dehydrogenase revealed a second-order association reaction (27), whereas the renaturation kinetics of the cytoplasmic enzyme, also a homodimer, were governed by a first-order rate-limiting step (28).

A first-order rate-limiting reaction can result from folding events on the monomer level or from structural rearrangements of an already dimerized protein. The comparative analysis of homo- and heterodimerization revealed identical kinetics for the formation of the disulfide-bonded AA or BB homodimers, suggesting that their renaturation pathways do not differ significantly, e.g. that folding of the two different monomeric chains into association competent molecules, association of these monomers into homodimers, and, finally, formation of intermolecular disulfide bridges do not exhibit significantly different pathways when renaturation was started either from the unfolded and reduced pure A- or B-chains. In contrast, the AB heterodimers were formed three times more rapidly compared with the formation of the homodimers. Assuming a rate-determining first-order step on the level of monomer folding and observing identical homodimerization kinetics is not contradictive if both monomeric isoforms exhibit identical folding kinetics prior to the formation of the dimer. But a rate-determining first-order step on the level of monomer folding should also result in the same kinetics for homo- and heterodimerization if both monomeric isoforms exhibit identical folding kinetics. However, we observe that heterodimerization of PDGF-AB occurs three times more rapidly than homodimerization. These results clearly exclude the possibility that the rate-determining first-order step can be assigned to conformational folding steps on the level of the not yet dimerized monomer but point clearly to structural rearrangements on the level of the dimerized but not yet disulfide-bonded dimer as the pace maker of renaturation. In this case, the different monomers can fold on identical pathways as the experimental results strongly suggest; however, once dimerized but not yet disulfide-bonded, the formation of the cystine bonds between the different chains must be facilitated between the PDGF-A and -B monomer compared with disulfide-bonding between identical chains. The results also show that a statistically and diffusion controlled encounter of the different monomers must be reversible, i.e. that non-covalent monomer association and dissociation must occur prior to the formation of intermolecular disulfide bonds under the conditions studied. Once connected by intermolecular disulfide bonds, however, there are no indications for subunit exchange processes (data not shown). The results from the kinetic studies on the folding and assembly of PDGF are summarized in the model depicted in Fig. 8.


View larger version (7K):
[in this window]
[in a new window]
 
Fig. 8.   Basic model for the formation of disulfide-bonded PDGF dimers from unfolded and reduced PDGF monomers. In this scheme Munfolded represents the unfolded and reduced PDGF monomers, which are subjected to SEC under conditions allowing refolding and disulfide bond reshuffling. M* signifies the PDGF monomer recovered directly after SEC in the eluate fraction. The reaction includes the transformation of M* into association competent monomers Mfolded, the subsequent encounter of Mfolded with another Mfolded into a non-covalently associated dimer (MM)*, the first-order rate determining structural rearrangements yielding the not yet disulfide-bonded dimer D*, which can be transformed through intermolecular disulfide-bonding into the native growth factor Dnative. The model additionally includes the formation of non-native off-pathway folding products Mmisfolded incompetent for the formation of native disulfide-bonded PDGF dimers.

The kinetically preferred formation of the heterodimeric growth factor should also affect the isoform distribution. Statistically an isoform distribution of 1:2:1 is expected when refolding occurs from an equimolar mixture of A- and B-chains. However, three times faster heterodimerization compared with homodimerization should result in an isoform distribution of 1:6:1, which accounts for 12.5% PDGF-AA, 75% PDGF-AB, and 12.5% PDGF-BB. A similar isoform distribution was reached when Chinese hamster ovary cells were used for coexpression of the genes encoding the PDGF-A and -B chains (19% AA, 69% AB, and 12% BB; Ref. 29).

The strong dependence of the kinetic constant of the rate-limiting renaturation step on the concentration of the denaturant GdnHCl strongly suggests that general structural rearrangements on the level of the non-covalently associated but not yet disulfide-bonded dimer determine the speed of renaturation. Finally, similar activation enthalpies of hetero- and homodimerization indicate that preferential heterodimerization must be controlled by entropic factors resulting in a more favorable positioning of the cysteines from different chains for the formation of the intermolecular disulfide bonds compared with disulfide bond formation between identical chains.

    ACKNOWLEDGEMENT

We are grateful to F. X. Schmid for useful comments concerning the interpretation of the Arrhenius plot data.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Current address: Aventis Pharma Deutschland GmbH, 65926 Frankfurt, Germany.

§ Current address: Cytos Biotechnology AG, Wagistrasse 25, 8952 Zürich-Schlieren, Switzerland.

To whom correspondence should be addressed. Tel.: 49-531-6181-126; Fax: 49-531-6181-111; E-mail: URI@gbf.de.

Published, JBC Papers in Press, March 3, 2003, DOI 10.1074/jbc.M212317200

    ABBREVIATIONS

The abbreviations used are: PDGF, platelet-derived growth factor; GdnHCl, guanidinium hydrochloride; SEC, size exclusion chromatography.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Ross, R., Raines, E. W., and Bowen-Pope, D. F. (1986) Cell 46, 155-169[Medline] [Order article via Infotrieve]
2. Heldin, C.-H. (1992) EMBO J. 11, 4251-4259[Medline] [Order article via Infotrieve]
3. Meyer-Ingold, W., and Eichner, W. (1995) Cell Biol. Int. 19, 389-398[CrossRef][Medline] [Order article via Infotrieve]
4. Meyer-Ingold, W. (1993) Trends Biotechnol. 11, 387-392[Medline] [Order article via Infotrieve]
5. Isaacs, N. W. (1995) Curr. Opin. Struct. Biol. 5, 391-395[CrossRef][Medline] [Order article via Infotrieve]
6. Gilbertson, D. G., Duff, M. E., West, J. W., Kelly, J. D., Sheppard, P. O., Hofstrand, P. D., Gao, Z., Shoemaker, K., Bukowski, T. R., Moore, M., Feldhaus, A. L., Humes, J. M., Palmer, T. E., and Hart, C. E. (2001) J. Biol. Chem. 276, 27406-27414[Abstract/Free Full Text]
7. LaRochelle, W. J., Jeffers, M., McDonald, W. F., Chillakuru, R. A., Giese, N. A., Lokker, N. A., Sullivan, C., Boldog, F. L., Yang, M., Vernet, C., Burgess, C. E., Fernandes, E., Deegler, L. L., Rittman, B., Shimkets, J., Shimkets, R. A., Rothberg, J. M., and Lichenstein, H. S. (2001) Nat. Cell Biol. 3, 517-521[CrossRef][Medline] [Order article via Infotrieve]
8. Betsholtz, C., Johnsson, A., Heldin, C.-H., Westermark, B., Lind, P., Urdea, M. S., Eddy, R., Shows, T. B., Philpott, K., Mellor, A. L., Knott, T. J., and Scott, J. (1986) Nature 320, 695-699[Medline] [Order article via Infotrieve]
9. Hannink, M., and Donoghue, D. J. (1989) Biochim. Biophys. Acta 989, 1-10[CrossRef][Medline] [Order article via Infotrieve]
10. Heldin, C. H., and Westermark, B. (1989) Trends Genet. 5, 108-111[CrossRef][Medline] [Order article via Infotrieve]
11. Hammacher, A., Hellman, U., Johnsson, A., Östman, A., Gunnarsson, K., Westermark, B., Wasteson, Å., and Heldin, C.-H. (1988) J. Biol. Chem. 263, 16493-16498[Abstract/Free Full Text]
12. Hoppe, J., Weich, H. A., Eichner, W., and Tatje, D. (1990) Eur. J. Biochem. 187, 207-214[Abstract]
13. Schneppe, B., Eichner, W., and McCarthy, J. E. G. (1994) Gene (Amst.) 143, 201-209[Medline] [Order article via Infotrieve]
14. Müller, C., and Rinas, U. (1999) J. Chromatogr. A 855, 203-213[CrossRef][Medline] [Order article via Infotrieve]
15. Oefner, C., D'Arcy, A., Winkler, F. K., Eggimann, B., and Hosang, M. (1992) EMBO J. 11, 3921-3926[Abstract]
16. Jaenicke, R., and Rudolph, R. (1986) Methods Enzymol. 131, 218-250[Medline] [Order article via Infotrieve]
17. Jaenicke, R. (1991) Biochemistry 30, 3147-3161[Medline] [Order article via Infotrieve]
18. Philo, J. S., Rosenfeld, R., Arakawa, T., Wen, J., and Narhi, L. O. (1993) Biochemistry 32, 10812-10818[Medline] [Order article via Infotrieve]
19. Rattenholl, A., Ruoppolo, M., Flagiello, A., Monti, M., Vinci, F., Marino, G., Lilie, H., Schwarz, E., and Rudolph, R. (2001) J. Mol. Biol. 305, 523-533[CrossRef][Medline] [Order article via Infotrieve]
20. Muller, Y. A., Heiring, C., Misselwitz, R., Welfle, K., and Welfle, H. (2002) J. Biol. Chem. 277, 43410-43416[Abstract/Free Full Text]
21. Kenney, W. C., Haniu, M., Herman, A. C., Arakawa, T., Costigan, V. J., Lary, J., Yphantis, D. A., and Thomason, A. R. (1994) J. Biol. Chem. 269, 12351-12359[Abstract/Free Full Text]
22. Prestrelski, S. J., Arakawa, T., Duker, K., Kenney, W. C., and Narhi, L. O. (1994) Int. J. Pept. Protein Res. 44, 357-363[Medline] [Order article via Infotrieve]
23. Raines, E. W., and Ross, R. (1985) Methods Enzymol. 109, 749-773[Medline] [Order article via Infotrieve]
24. Seeger, A., Schneppe, B., McCarthy, J. E. G., Deckwer, W.-D., and Rinas, U. (1995) Enzyme Microb. Technol. 17, 947-953[CrossRef]
25. Milla, M. E., and Sauer, R. T. (1994) Biochemistry 33, 1125-1133[Medline] [Order article via Infotrieve]
26. Buchner, J., and Rudolph, R. (1991) Bio/Technology 9, 157-162[Medline] [Order article via Infotrieve]
27. Jaenicke, R., Rudolph, R., and Heider, I. (1979) Biochemistry 18, 1217-1223[Medline] [Order article via Infotrieve]
28. Rudolph, R., Fuchs, I., and Jaenicke, R. (1986) Biochemistry 25, 1662-1669[Medline] [Order article via Infotrieve]
29. Östman, A., Rall, L., Hammacher, A., Wormstead, M. A., Coit, D., Valenzuela, P., Betsholtz, C., Westermark, B., and Heldin, C.-H. (1988) J. Biol. Chem. 263, 16202-16208[Abstract/Free Full Text]
30. Scheufler, C., Sebald, W., and Hülsmeyer, M. (1999) J. Mol. Biol. 287, 103-115[CrossRef][Medline] [Order article via Infotrieve]
31. Hinck, A. P., Archer, S. J., Qian, S. W., Roberts, A. B., Sporn, M. B., Weatherbee, J. A., Tsang, M. L.-S., Lucas, R., Zhang, B.-L., Wenker, J., and Torchia, D. A. (1996) Biochemistry 35, 8517-8534[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.



This Article
Abstract
Full Text (PDF)
An addition or correction has been published
All Versions of this Article:
278/20/18330    most recent
M212317200v1
Purchase Article
View Shopping Cart
Alert me when this article is cited
Alert me if a correction is posted
Citation Map
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Copyright Permissions
Google Scholar
Articles by Müller, C.
Articles by Rinas, U.
Articles citing this Article
PubMed
PubMed Citation
Articles by Müller, C.
Articles by Rinas, U.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   Biochemistry and Molecular Biology Education 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.